FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044984820> ?p ?o ?g. }

• W2044984820 endingPage "1064" @default.
• W2044984820 startingPage "1057" @default.
• W2044984820 abstract "A high performance liquid chromatography-tandem mass spectrometry (LC–MS/MS) method has been developed for the simultaneous determinations of total viramidine (viramidine, viramidine monophosphate, viramidine diphosphate, and viramidine triphosphate) and total ribavirin (ribavirin, ribavirin monophosphate, ribavirin diphosphate, and ribavirin triphosphate) in monkey red blood cells (RBC). The method involves the addition of internal standards and perchloric acid, conversion of viramidine or ribavirin phosphorylated metabolites to viramidine or ribavirin, purification with an aminopropyl (NH2) solid phase extraction (SPE) cartridge, and LC–MS/MS analysis. The MS/MS is selected to monitor m/z 245 → 113, 250 → 113, 244 → 112, and 249 → 112 for ribavirin, [13C]ribavirin, viramidine, and [13C]viramidine, respectively, using positive electrospray ionization. The calibration curves are linear over a concentration range of 100–10,000 ng/mL (0.412–41.2 μM) with a lower limit of quantification (LLOQ) of 100 ng/mL for both compounds. Mean inter-assay recoveries for ribavirin are 101%, 98.9%, and 96.0%, with coefficient of variance (%CV) values between 1.95 and 4.50% for 100, 1000, and 10,000 ng/mL quality control (QC) samples, respectively. Mean inter-assay recoveries for viramidine are 96.3%, 101%, and 102%, with coefficient of variation (%CV) values between 3.61 and 7.22%, for 100, 1000, and 10,000 ng/mL QC samples, respectively. Over-curve dilution QC at 400 μg/mL (1639 μM) for both viramidine and ribavirin are used to ensure the dilution accuracy (25 X dilutions) for monkey samples. The method has been used to simultaneously determine the total concentrations of ribavirin and viramidine in monkey RBC following 5, 15, and 36 weeks dosing of viramidine or ribavirin (60 mg/kg). The concentrations of total ribavirin following ribavirin dosing are 1242 μM at week 5, 1257 μM at week 15, and 1146 μM at week 36. The concentrations of total ribavirin following viramidine dosing are 634 μM at week 5, 716 μM at week 15, and 683 μM at week 36. Only small amounts of viramidine are detected in RBC following viramidine dosing, 7.80 μM at week 5, 6.63 μM at week 15, and 10.4 μM at week 36. The results suggest that ribavirin levels in RBC were at steady state at week 5 of ribavirin or viramidine dosing. At steady state, ribavirin levels in RBC are approximately 2× after ribavirin dosing than viramidine dosing. The relatively small percentage of viramidine in RBC suggests that viramidine either poorly penetrated into RBC or was extensively converted to ribavirin following entry into RBC." @default.
• W2044984820 created "2016-06-24" @default.
• W2044984820 creator A5047781834 @default.
• W2044984820 creator A5050452018 @default.
• W2044984820 creator A5053331867 @default.
• W2044984820 creator A5062733440 @default.
• W2044984820 creator A5071536769 @default.
• W2044984820 date "2007-02-01" @default.
• W2044984820 modified "2023-09-25" @default.
• W2044984820 title "LC–MS/MS method for simultaneous determination of viramidine and ribavirin levels in monkey red blood cells" @default.
• W2044984820 cites W1982301628 @default.
• W2044984820 cites W1982908339 @default.
• W2044984820 cites W1987116001 @default.
• W2044984820 cites W1992431747 @default.
• W2044984820 cites W1992634057 @default.
• W2044984820 cites W2012051375 @default.
• W2044984820 cites W2027123593 @default.
• W2044984820 cites W2027907833 @default.
• W2044984820 cites W2027933534 @default.
• W2044984820 cites W2035935954 @default.
• W2044984820 cites W2051272149 @default.
• W2044984820 cites W2053803207 @default.
• W2044984820 cites W2057407143 @default.
• W2044984820 cites W2061824806 @default.
• W2044984820 cites W2067617284 @default.
• W2044984820 cites W2076024060 @default.
• W2044984820 cites W2079436816 @default.
• W2044984820 cites W2087785245 @default.
• W2044984820 cites W2107426863 @default.
• W2044984820 cites W2124857355 @default.
• W2044984820 cites W2136584060 @default.
• W2044984820 cites W2160930473 @default.
• W2044984820 doi "https://doi.org/10.1016/j.jpba.2006.09.001" @default.
• W2044984820 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17029670" @default.
• W2044984820 hasPublicationYear "2007" @default.
• W2044984820 type Work @default.
• W2044984820 sameAs 2044984820 @default.
• W2044984820 citedByCount "22" @default.
• W2044984820 countsByYear W20449848202012 @default.
• W2044984820 countsByYear W20449848202014 @default.
• W2044984820 countsByYear W20449848202015 @default.
• W2044984820 countsByYear W20449848202016 @default.
• W2044984820 countsByYear W20449848202017 @default.
• W2044984820 countsByYear W20449848202018 @default.
• W2044984820 crossrefType "journal-article" @default.
• W2044984820 hasAuthorship W2044984820A5047781834 @default.
• W2044984820 hasAuthorship W2044984820A5050452018 @default.
• W2044984820 hasAuthorship W2044984820A5053331867 @default.
• W2044984820 hasAuthorship W2044984820A5062733440 @default.
• W2044984820 hasAuthorship W2044984820A5071536769 @default.
• W2044984820 hasConcept C104317684 @default.
• W2044984820 hasConcept C119128265 @default.
• W2044984820 hasConcept C135763542 @default.
• W2044984820 hasConcept C162356407 @default.
• W2044984820 hasConcept C185592680 @default.
• W2044984820 hasConcept C2780040827 @default.
• W2044984820 hasConcept C31827203 @default.
• W2044984820 hasConcept C40684141 @default.
• W2044984820 hasConcept C43617362 @default.
• W2044984820 hasConcept C55493867 @default.
• W2044984820 hasConcept C71043704 @default.
• W2044984820 hasConcept C81426234 @default.
• W2044984820 hasConcept C89838059 @default.
• W2044984820 hasConceptScore W2044984820C104317684 @default.
• W2044984820 hasConceptScore W2044984820C119128265 @default.
• W2044984820 hasConceptScore W2044984820C135763542 @default.
• W2044984820 hasConceptScore W2044984820C162356407 @default.
• W2044984820 hasConceptScore W2044984820C185592680 @default.
• W2044984820 hasConceptScore W2044984820C2780040827 @default.
• W2044984820 hasConceptScore W2044984820C31827203 @default.
• W2044984820 hasConceptScore W2044984820C40684141 @default.
• W2044984820 hasConceptScore W2044984820C43617362 @default.
• W2044984820 hasConceptScore W2044984820C55493867 @default.
• W2044984820 hasConceptScore W2044984820C71043704 @default.
• W2044984820 hasConceptScore W2044984820C81426234 @default.
• W2044984820 hasConceptScore W2044984820C89838059 @default.
• W2044984820 hasIssue "3" @default.
• W2044984820 hasLocation W20449848201 @default.
• W2044984820 hasLocation W20449848202 @default.
• W2044984820 hasOpenAccess W2044984820 @default.
• W2044984820 hasPrimaryLocation W20449848201 @default.
• W2044984820 hasRelatedWork W2014605936 @default.
• W2044984820 hasRelatedWork W2062375825 @default.
• W2044984820 hasRelatedWork W2078150477 @default.
• W2044984820 hasRelatedWork W2079130042 @default.
• W2044984820 hasRelatedWork W2114007293 @default.
• W2044984820 hasRelatedWork W2200897360 @default.
• W2044984820 hasRelatedWork W2349737994 @default.
• W2044984820 hasRelatedWork W2357498526 @default.
• W2044984820 hasRelatedWork W253317893 @default.
• W2044984820 hasRelatedWork W2731747081 @default.
• W2044984820 hasVolume "43" @default.
• W2044984820 isParatext "false" @default.
• W2044984820 isRetracted "false" @default.
• W2044984820 magId "2044984820" @default.
• W2044984820 workType "article" @default.